Argent Advisors, Inc. Novartis Ag Transaction History

Argent Advisors, Inc.

$267 Million
Q3 2024

A detailed history of Argent Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Argent Advisors, Inc. holds 2,673 shares of NVS stock, worth $277,484. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,673

Previous 3,343 20.04%

Holding current value

$277,484

Previous $355,000 13.52%

% of portfolio

0.11%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $71,107 - $80,996	-670 Reduced 20.04%	2,673 $307,000
Q1 2024 May 01, 2024	BUY	$95.27 - $108.47 $42,871 - $48,811	450 Added 15.55%	3,343 $323,000
Q4 2023 Feb 08, 2024	SELL	$92.27 - $101.54 $37,830 - $41,631	-410 Reduced 12.41%	2,893 $292,000
Q1 2023 Apr 21, 2023	BUY	$80.03 - $92.81 $8,003 - $9,281	100 Added 3.12%	3,303 $303,000
Q3 2022 Nov 08, 2022	BUY	$74.61 - $87.26 $7,461 - $8,726	100 Added 3.22%	3,203 $243,000
Q2 2022 Aug 08, 2022	SELL	$80.52 - $93.75 $1,851 - $2,156	-23 Reduced 0.74%	3,103 $262,000
Q3 2021 Nov 05, 2021	BUY	$81.78 - $95.14 $10,631 - $12,368	130 Added 4.34%	3,126 $256,000
Q2 2021 Aug 02, 2021	BUY	$85.24 - $94.15 $25,572 - $28,245	300 Added 11.13%	2,996 $273,000
Q1 2021 Apr 27, 2021	SELL	$83.5 - $98.47 $85,420 - $100,734	-1,023 Reduced 27.51%	2,696 $230,000
Q4 2020 Feb 11, 2021	BUY	$78.07 - $94.43 $9,212 - $11,142	118 Added 3.28%	3,719 $351,000
Q3 2020 Oct 29, 2020	BUY	$82.14 - $91.0 $43,944 - $48,685	535 Added 17.45%	3,601 $313,000
Q2 2020 Aug 11, 2020	BUY	$80.93 - $91.1 $248,131 - $279,312	3,066 New	3,066 $267,000
Q1 2020 Apr 23, 2020	SELL	$70.67 - $99.01 $203,458 - $285,049	-2,879 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $242,843 - $274,570	2,879 New	2,879 $272,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argent Advisors, Inc. with notifications on news.

Account

Argent Advisors, Inc. Novartis Ag Transaction History